Drug details

Jornay PM (methylphenidate hydrochloride extended-release capsules)

type of Stimulants, ADHD Agents

Jornay PM (methylphenidate hydrochloride) is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older.

This drug may have the following side effects:

• fast heartbeats,
• chest pain,
• fainting,
• agitation,
• irregular heartbeats,
• impulsive behavior,
• irritableness,
• depression,
• increased blood pressure,
• hallucinations,
• racing thoughts,
• decreased need for sleep,
• changes in behavior,
• stroke,
• heart attack,
• feeling overly happy or “high”,
• extreme restlessness,
• engaging in risky behavior,  
• prolonged erection or a painful erection of the penis,
• numbness or cool feeling in fingers, toes, ears and tip of the nose, and
• color changes of the skin

The following drugs are related to Jornay PM, either as a replacement or used together:

• Adderall (amphetamine, dextroamphetamine mixed salts)
• Strattera (atomoxetine hcl)
• Kapvay (clonidine hydrochloride extended-release tablets)
• Intuniv (guanfacine)
• Vyvanse (lisdexamfetamine dimesylate)
• Ritalin (methylphenidate hcl)
• Ritalin LA (methylphenidate hydrochloride extended-release capsules)